ZIMMERMANN, MARTINA
ZIMMERMANN, MARTINA
Universita' degli Studi di MILANO
Artificial neural networks allow the use of simultaneous measurements of Alzheimer disease markers for early detection of the disease
2005 M. Diluca, E. Grossi, B. Borroni, M. Zimmermann, E. Marcello, F. Colciaghi, F. Gardoni, M. Intraligi, A. Padovani, M. Buscema
Molecular rationale for the pharmacological treatment of Alzheimer's disease
2005 M. Zimmermann, F. Gardoni, M. Di Luca
Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients
2005 M. Zimmermann, B. Borroni, F. Cattabeni, A. Padovani, M. Di Luca
Platelet APP, BACE and ADAM 10 levels in pre-clinical Alzheimer disease
2004 A. Padovani, B. Borroni, F. Colciaghi, M. Zimmermann, E. Marcello, F. Cattabeni, M.M.G. Di Luca
Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts
2004 F. Colciaghi, B. Borroni, M. Zimmermann, C. Bellone, A. Longhi, A. Padovani, F. Cattabeni, Y. Christen, M. Di Luca
Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines
2004 M. Zimmermann, F. Gardoni, E. Marcello, F. Colciaghi, B. Borroni, A. Padovani, F. Cattabeni, M. Di Luca
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease
2004 F. Colciaghi, E. Marcello, B. Borroni, M. Zimmermann, C. Caltagirone, F. Cattabeni, A. Padovani, M. Di Luca
Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer's disease
2002 M. Zimmermann, F. Colciaghi, F. Cattabeni, M.M.G. Di Luca, M